Full Measure has learned the FDA is planning a new study on TV advertising of prescription drugs. It's a multi-billion dollar industry benefiting both pharmaceutical companies and the television networks paid to run the ads. Supporters say patients benefit too. But almost nowhere in the world is it allowed except here. And with prescription drugs a leading cause of death and injury, we investigate the Pill Pitch.
During a recent vote at the annual meeting in Atlanta, the nation's American Medical Association decided that they were going to call for a ban on consumer drug commercials in magazines and television commercials.
This vote "reflects concerns among physicians about the negative impact of commercially driven promotions, and the role that marketing costs play in fueling escalating drug prices," said AMA Board Chair-elect Patrice A. Harris in a statement announcing the votes result. "Direct-to-consumer advertising also inflates demand for new and more expensive drugs, even when these drugs may not be appropriate."
In his excellent book, Generation RX, Greg Critser traces the history of direct-to-consumer advertising and unveils early concerns from major drug companies that it would raise fears of disease, sell unnecessary pills and corrupt the doctor/patient relationship. That's exactly what has happened and Pharma is lamenting it all the way to the bank.
In the past 5 years, the science of genetic engineering has made giant strides. Starting from scratch using lifeless chemicals, scientists are now able to create viruses, such as the polio virus. Technically, viruses are not "alive" because they require cells to survive. But soon - perhaps some time this year - scientists expect to create bacteria, which are definitely alive. From there, it will be a short step to manufacturing new forms of life that have never existed on Earth before. This startling new enterprise is called "synthetic biology."
Comment:
Geographic distribution and burden of cancers in India - 2018